Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus: in-depth evaluation in endoscopic mucosal resections.


Journal

Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 01 10 2018
revised: 21 11 2018
accepted: 03 12 2018
pubmed: 4 3 2019
medline: 30 5 2019
entrez: 4 3 2019
Statut: ppublish

Résumé

There is increasing interest in p53 immunohistochemistry as an adjunct to haematoxylin and eosin (H&E) assessment for dysplasia in oesophageal Barrett's mucosa; however, published information on the patterns of staining remains scant. Here, we present descriptions of normal and aberrant p53 staining in non-neoplastic and dysplastic Barrett's mucosa in endoscopic mucosal resections. A retrospective series of archival endoscopic mucosal resections for biopsy proven dysplasia at our institution were retrieved for this study, comprising 28 sections from 23 patients. p53 immunohistochemistry was performed using an in-house optimised protocol and the staining pattern assessed in H&E confirmed non-neoplastic, dysplastic and neoplastic areas of Barrett's mucosa with regard to individual cell intensity and location of positive cells with respect to gland microanatomy. In non-neoplastic epithelium, normal p53 staining was weak, heterogenous and localised to the crypts. In dysplastic epithelium, p53 over-expression was seen which was of moderate to strong intensity in either a crypt predominant location or diffuse involving crypt and surface epithelium. The crypt predominant pattern was observed more commonly in low grade dysplasia while the diffuse pattern was more commonly seen in high grade dysplasia. In a minority of cases, there was complete loss of p53 staining in dysplastic epithelium and contiguous neoplasia (null phenotype). p53 immuno-expression in non-neoplastic and dysplastic Barrett's mucosa is distinctive when interpreted with regard to cell intensity and gland microanatomy. We propose that these staining patterns may assist in the interpretation of dysplasia in endoscopic biopsies of Barrett's mucosa.

Identifiants

pubmed: 30826014
pii: S0031-3025(18)30508-7
doi: 10.1016/j.pathol.2018.12.415
pii:
doi:

Substances chimiques

Tumor Suppressor Protein p53 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

253-260

Informations de copyright

Copyright © 2019 Royal College of Pathologists of Australasia. All rights reserved.

Auteurs

Christopher Toon (C)

Histopath Diagnostic Specialists, North Ryde, NSW, Australia. Electronic address: ctoon@med.usyd.edu.au.

Benjamin Allanson (B)

Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.

Connull Leslie (C)

PathWest Laboratory Medicine, Perth, WA, Australia.

Nathan Acott (N)

PathWest Laboratory Medicine, Perth, WA, Australia.

Bob Mirzai (B)

PathWest Laboratory Medicine, Perth, WA, Australia; School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.

Spiro Raftopoulos (S)

Department of Gastroenterology, Sir Charles Gairdner Hospital, Perth, WA, Australia.

Marian Priyanthi Kumarasinghe (MP)

PathWest Laboratory Medicine, Perth, WA, Australia; School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH